News
Stay up to date on topics that are important to Nurse Practitioners.
-
Recent AANP Letter to Congress Expresses Support for ICAN Act
The American Association of Nurse Practitioners (AANP) and other healthcare organizations recently sent a letter to the leaders…
-
First COVID-19 At-Home Test Receives Marketing Authorization from FDA
On June 6, the Cue COVID-19 Molecular Test received marketing authorization from the FDA. Intended to detect genetic…
-
Wildfire Smoke Increases Risk of Lung Disease, Inflammation, Other Health Risks
Unseasonable heat and drought contributed to an unprecedented outbreak of wildfires across eastern Canada in April and May.…
-
What the End of the COVID-19 Public Health Emergency Means for Healthcare Professionals
On May 11th, the national Public Health Emergency (PHE) for COVID-19, declared under Section 319 of the Public…
-
First Drug to Treat Agitation Symptoms Associated with Alzheimer’s-Related Dementia Approved by FDA
On May 11th, the FDA announced its supplemental approval of Rexulti (brexpiprazole) oral tablets for treatment of agitation…
-
First Respiratory Syncytial Virus (RSV) Vaccine for Adults 60 Years and Older Receives FDA Approval
On May 3rd, the FDA approved Arexvy, the first RSV vaccine available in the United States for individuals…
-
FDA Authorizes Changes to Simplify COVID-19 Vaccination Schedule
In order to simplify the vaccination schedule for most Americans, the U.S. Food and Drug Administration recently amended…
-
STI Cases in the United States Continue to Escalate
Recent data from the CDC shows that reported cases of sexually transmitted infections (STIs) have increased between 2020…
-
FDA Approves Naloxone Nasal Spray for Nonprescription Use
The U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray, for over-the-counter nonprescription…
-
Florida Proposes Bill to Restrict Use of Title “Dr.”
A recent bill filed in the Florida State Legislature would place significant restrictions on the use of the…
-
Two Cases of the H5N1 Strain of Avian Flu Found in Humans
Epidemiologists around the world are keeping a close eye on the H5N1 strain of avian influenza. Identified in…
-
FDA Recommends Approval for Two RSV Vaccines for Older Adults
An FDA advisory committee recommended that the agency approve two RSV vaccines for adults, one produced by GlaxoSmithKline,…
Trending
-
FDA Approved Semaglutide Injection to Reduce Risk of Serious Heart Problems in Overweight Adults
-
The Role of Pharmacogenomics in Precision Mental Healthcare
-
OTC COVID-19 Diagnostic Tests May Have an Extended Shelf Life
-
AANP Offers Resources to Help NPs Detect and Treat Ulcerative Colitis
-
Multistate Outbreak of Salmonella Linked to Cucumbers
-
5 Key Benefits of Getting a Second Certification as a Nurse Practitioner
-
8 Key Tips for Effective Communication During Pediatric ENT Exams
-
Normalizing Anxiety: How NPs Can Guide Patients to Make Healthier Choices
-
CDC Endorses Lowering Pneumococcal Vaccination Age from 65 to 50
-
FDA Proposes Ban on Over-the-Counter Oral Nasal Congestion Medication
-
Using Technology to Combat Drug-Drug Interactions
-
Building a Strong Professional Nursing Network as a New Nurse Practitioner
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.